U.S. Physical Therapy (NYSE:USPH) Price Target Cut to $110.00 by Analysts at JPMorgan Chase & Co.

U.S. Physical Therapy (NYSE:USPH) had its price target trimmed by JPMorgan Chase & Co. from $120.00 to $110.00 in a research note published on Wednesday morning,Benzinga reports. The brokerage currently has an overweight rating on the stock.

Several other equities analysts have also issued reports on USPH. Citizens Jmp raised U.S. Physical Therapy to a “strong-buy” rating in a research note on Monday, December 16th. StockNews.com lowered shares of U.S. Physical Therapy from a “hold” rating to a “sell” rating in a research note on Friday, February 28th. Bank of America raised shares of U.S. Physical Therapy from a “neutral” rating to a “buy” rating and increased their target price for the stock from $100.00 to $115.00 in a research note on Monday, December 16th. Barrington Research decreased their price target on shares of U.S. Physical Therapy from $108.00 to $98.00 and set an “outperform” rating for the company in a research note on Friday, February 28th. Finally, William Blair reissued a “market perform” rating on shares of U.S. Physical Therapy in a research report on Thursday, February 27th. One research analyst has rated the stock with a sell rating, one has issued a hold rating, four have issued a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $109.00.

U.S. Physical Therapy Price Performance

Shares of NYSE USPH opened at $72.52 on Wednesday. The company has a market capitalization of $1.10 billion, a PE ratio of 77.14, a P/E/G ratio of 3.54 and a beta of 1.51. The company has a quick ratio of 1.78, a current ratio of 1.78 and a debt-to-equity ratio of 0.27. U.S. Physical Therapy has a twelve month low of $72.27 and a twelve month high of $113.63. The firm has a fifty day simple moving average of $84.85 and a 200 day simple moving average of $86.99.

U.S. Physical Therapy (NYSE:USPH) last issued its quarterly earnings results on Wednesday, February 26th. The company reported $0.65 earnings per share for the quarter, missing analysts’ consensus estimates of $0.69 by ($0.04). The business had revenue of $180.45 million for the quarter, compared to analyst estimates of $173.10 million. U.S. Physical Therapy had a return on equity of 8.11% and a net margin of 3.54%. On average, sell-side analysts forecast that U.S. Physical Therapy will post 2.67 EPS for the current year.

U.S. Physical Therapy Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, April 11th. Shareholders of record on Friday, March 14th will be paid a $0.45 dividend. This represents a $1.80 dividend on an annualized basis and a dividend yield of 2.48%. This is a positive change from U.S. Physical Therapy’s previous quarterly dividend of $0.44. The ex-dividend date of this dividend is Friday, March 14th. U.S. Physical Therapy’s dividend payout ratio (DPR) is 97.83%.

Insider Activity

In related news, COO Graham D. Reeve sold 1,730 shares of the firm’s stock in a transaction dated Friday, March 7th. The shares were sold at an average price of $82.11, for a total transaction of $142,050.30. Following the transaction, the chief operating officer now directly owns 7,168 shares of the company’s stock, valued at $588,564.48. This trade represents a 19.44 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Corporate insiders own 1.70% of the company’s stock.

Institutional Investors Weigh In On U.S. Physical Therapy

Several institutional investors and hedge funds have recently added to or reduced their stakes in the company. Vanguard Group Inc. increased its position in shares of U.S. Physical Therapy by 0.6% during the fourth quarter. Vanguard Group Inc. now owns 1,084,197 shares of the company’s stock valued at $96,179,000 after acquiring an additional 6,393 shares during the last quarter. Copeland Capital Management LLC raised its stake in shares of U.S. Physical Therapy by 9.5% during the 4th quarter. Copeland Capital Management LLC now owns 839,356 shares of the company’s stock worth $74,459,000 after purchasing an additional 72,715 shares during the period. State Street Corp raised its stake in shares of U.S. Physical Therapy by 17.5% during the 3rd quarter. State Street Corp now owns 667,868 shares of the company’s stock worth $56,522,000 after purchasing an additional 99,244 shares during the period. Southernsun Asset Management LLC boosted its holdings in shares of U.S. Physical Therapy by 4.5% in the 4th quarter. Southernsun Asset Management LLC now owns 571,809 shares of the company’s stock worth $50,725,000 after buying an additional 24,698 shares during the last quarter. Finally, Dimensional Fund Advisors LP grew its position in U.S. Physical Therapy by 1.9% during the fourth quarter. Dimensional Fund Advisors LP now owns 426,298 shares of the company’s stock valued at $37,818,000 after buying an additional 7,890 shares during the period.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.